To test if current therapeutic drugs of MM were able to affect expression of SDHA, we used 10.67 μM bortezomib, 2.48 mM lenalidomide, 6 μM chidamide and isometric DMSO to treat H929 cells for 24 h, respectively. This evidence concerns the gene SDHA and Miyoshi myopathy.